BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16749765)

  • 1. Inclusion complexation of novocaine by beta-cyclodextrin in aqueous solutions.
    Iglesias E
    J Org Chem; 2006 Jun; 71(12):4383-92. PubMed ID: 16749765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion complexes of N-sulfamoyloxazolidinones with beta-cyclodextrin.
    Kadri M; Djemil R; Abdaoui M; Winum JY; Coutrot F; Montero JL
    Bioorg Med Chem Lett; 2005 Feb; 15(4):889-94. PubMed ID: 15686881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ester hydrolysis and nitrosative deamination of novocaine in aqueous solutions.
    Iglesias-Martinez E; Brandariz I; Penedo F
    Chem Res Toxicol; 2006 Apr; 19(4):594-600. PubMed ID: 16608172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic study for the inclusion complex of carboxylic acids with cyclodextrin by the ultrasonic relaxation method.
    Nishikawa S; Kondo M
    J Phys Chem B; 2006 Dec; 110(51):26143-7. PubMed ID: 17181269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-guest complexation affected by pH and length of spacer for hydroxyazobenzene-modified cyclodextrins.
    Kuwabara T; Shiba K; Nakajima H; Ozawa M; Miyajima N; Hosoda M; Kuramoto N; Suzuki Y
    J Phys Chem A; 2006 Dec; 110(50):13521-9. PubMed ID: 17165879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexation study of brilliant cresyl blue with beta-cyclodextrin and its derivatives by UV-vis and fluorospectrometry.
    Zhang QF; Jiang ZT; Guo YX; Li R
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jan; 69(1):65-70. PubMed ID: 17433764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the 2:1 molecular recognition and inclusion behaviour between beta- and gamma-cyclodextrins and cinchonine.
    Wen X; Liu Z; Zhu T; Zhu M; Jiang K; Huang Q
    Bioorg Chem; 2004 Aug; 32(4):223-33. PubMed ID: 15210337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
    Hegge AB; Másson M; Kristensen S; Tønnesen HH
    Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-guest complexation of oxicam NSAIDs with beta-cyclodextrin.
    Banerjee R; Chakraborty H; Sarkar M
    Biopolymers; 2004 Nov; 75(4):355-65. PubMed ID: 15372483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and spectral investigation of inclusion complex of caffeic acid with hydroxypropyl-beta-cyclodextrin.
    Zhang M; Li J; Zhang L; Chao J
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1891-5. PubMed ID: 18722807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the supramolecular systems of 5-(2-hydroxy phenyl)-10,15,20-tris (4-methoxy phenyl) porphyrin with cyclodextrins.
    Kong LH; Guo YJ; Li XX; Pan JH
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Mar; 66(3):594-8. PubMed ID: 16859961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the inclusion complexation interaction of beta-cyclodextrin and beta-carotene by UV-Vis spectra].
    Feng GZ; Lu K; Li HP
    Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Sep; 24(9):1099-102. PubMed ID: 15762533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility, spectroscopic properties and photostability of Rhein/cyclodextrin inclusion complex.
    Petralito S; Zanardi I; Memoli A; Annesini MC; Travagli V
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Dec; 74(5):1254-9. PubMed ID: 19857988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on the inclusion behavior between meso-tetrakis(4-N-ethylpyridiniurmyl)porphyrin and beta-cyclodextrin derivatives.
    Xiliang G; Shaomin S; Chuan D; Feng F; Wong MS
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(3):413-8. PubMed ID: 15582808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity.
    Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM
    Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexation study of midazolam hydrochloride with beta-cyclodextrin: NMR spectroscopic study in solution.
    Ali SM; Upadhyay SK
    Magn Reson Chem; 2008 Jul; 46(7):676-9. PubMed ID: 18381674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Solubilization and complexation of the antileukotrienic drug Quinlukast in aqueous solutions of cyclodextrins].
    Kopecký F; Kopecká B
    Ceska Slov Farm; 2005 May; 54(3):137-40. PubMed ID: 15945461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pH and water-soluble polymers on the aqueous solubility of nimesulide in the absence and presence of beta-cyclodextrin derivatives.
    Alexanian C; Papademou H; Vertzoni M; Archontaki H; Valsami G
    J Pharm Pharmacol; 2008 Nov; 60(11):1433-9. PubMed ID: 18957163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic study of interaction between beta-cyclodextrin and aspirin by the ultrasonic relaxation method.
    Fukahori T; Kondo M; Nishikawa S
    J Phys Chem B; 2006 Mar; 110(9):4487-91. PubMed ID: 16509753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.